PARANEOPLASTIC CEREBELLAR DEGENERATION IN A PATIENT WITH CHEMOTHERAPY-RESPONSIVE OVARIAN-CANCER

被引:6
|
作者
MCCRYSTAL, M
ANDERSON, NE
JONES, RW
EVANS, BD
机构
[1] AUCKLAND HOSP,DEPT CLIN ONCOL,AUCKLAND,NEW ZEALAND
[2] AUCKLAND HOSP,DEPT NEUROL,AUCKLAND,NEW ZEALAND
[3] NATL WOMENS HOSP,AUCKLAND,NEW ZEALAND
[4] GREEN LANE HOSP,AUCKLAND 3,NEW ZEALAND
关键词
OVARIAN CANCER; PARANEOPLASTIC CEREBELLAR DEGENERATION;
D O I
10.1046/j.1525-1438.1995.05050396.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 54-year-old female with small volume residual stage III ovarian cancer had received two courses of carboplatin chemotherapy with obvious response, when she developed rapidly progressive neurological symptoms. Over a period of 48 h, an incapacitating syndrome of ataxia, nystagmus and dysarthria evolved. Central nervous system metastases were excluded by computed tomography scanning and cerebrospinal fluid cytology. Anti-Purkinje cell antibodies ('anti-Yo') detected in the serum confirmed the diagnosis of paraneoplastic cerebellar degeneration. Isolated reports have suggested that the clinical course of this condition can be ameliorated with high dose steroids and plasmapheresis. However, in this case the very early introduction of both these did not bring about any improvement in the patient's symptoms. She remained severely incapacitated and unable to care for herself for the remaining 15 months of her life. The patient died of progressive ovarian cancer that had become clinically evident 10 months after the onset of neurological symptoms. This case illustrates many of the classical features of this rare condition, and the world literature is reviewed.
引用
收藏
页码:396 / 399
页数:4
相关论文
共 50 条
  • [21] An Etiological Investigation of Paraneoplastic Cerebellar Degeneration in Ovarian Cancer Patients: A Systematic Review
    Fidahussain, Akbar A.
    Abid, Ali
    Paracha, Awais A.
    Jeevan, Varun E.
    Rueve, Joseph
    Engelhardt, Mckimmon
    Schrock, Cody
    Ghani, Sofia
    Nair, Hari K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
  • [22] CHEMOTHERAPY FOR OVARIAN-CANCER
    KAYE, SB
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (04) : 632 - 635
  • [23] CHEMOTHERAPY OF OVARIAN-CANCER
    OZOLS, RF
    YOUNG, RC
    SEMINARS IN ONCOLOGY, 1991, 18 (03) : 222 - 232
  • [24] Paraneoplastic Cerebellar Degeneration—A Rare Presentation of Ovarian Malignancy
    Sharma R.
    Radhakrishnan G.
    Radhika A.G.
    Singla A.
    The Journal of Obstetrics and Gynecology of India, 2016, 66 (Suppl 2) : 686 - 689
  • [25] CHEMOTHERAPY OF OVARIAN-CANCER
    MCVIE, JG
    BRITISH JOURNAL OF CANCER, 1986, 54 (01) : 141 - 142
  • [26] CHEMOTHERAPY OF OVARIAN-CANCER
    OZOLS, RF
    YOUNG, RC
    SEMINARS IN ONCOLOGY, 1984, 11 (03) : 251 - 263
  • [27] Subacute paraneoplastic cerebellar degeneration prior to development of cerebellar metastasis of an ovarian cancer - Two unusual complications of ovarian carcinomas
    Marlier, S
    Civatte, M
    de Jaureguiberry, JP
    Yao, N
    Gisserot, O
    Kologo, K
    Jaubert, D
    PRESSE MEDICALE, 1999, 28 (19): : 1018 - 1018
  • [28] Paraneoplastic cerebellar degeneration and primary fallopian cancer
    Hezer, S.
    Descargues, G.
    Vignals, C.
    Imbert, Y.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2019, 47 (7-8): : 610 - 612
  • [29] Paraneoplastic cerebellar degeneration as the first manifestation of cancer
    Lin, JT
    Lachmann, E
    Nagler, W
    JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2001, 10 (05): : 495 - 502
  • [30] BREAST-CANCER AND PARANEOPLASTIC CEREBELLAR DEGENERATION
    WATERHOUSE, DM
    NATALE, RB
    CODY, RL
    CANCER, 1991, 68 (08) : 1835 - 1841